GW501516 (also known as GW-501,516, GW1516, GSK-516, cardarine, and amongst performance enhancing drug communities as endurobol ) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.